Research ArticleNEUROPHARMACOLOGY
Characterization of the Potent and Highly Selective A2A Receptor Antagonists Preladenant and SCH 412348 [7-[2-[4-2,4-Difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in Rodent Models of Movement Disorders and Depression
Robert A. Hodgson, Rosalia Bertorelli, Geoffrey B. Varty, Jean E. Lachowicz, Angelo Forlani, Silva Fredduzzi, Mary E. Cohen-Williams, Guy A. Higgins, Francesco Impagnatiello, Elisa Nicolussi, Leonard E. Parra, Carolyn Foster, Ying Zhai, Bernie R. Neustadt, Andrew W. Stamford, Eric M. Parker, Angelo Reggiani and John C. Hunter
Journal of Pharmacology and Experimental Therapeutics July 2009, 330 (1) 294-303; DOI: https://doi.org/10.1124/jpet.108.149617
Robert A. Hodgson
Rosalia Bertorelli
Geoffrey B. Varty
Jean E. Lachowicz
Angelo Forlani
Silva Fredduzzi
Mary E. Cohen-Williams
Guy A. Higgins
Francesco Impagnatiello
Elisa Nicolussi
Leonard E. Parra
Carolyn Foster
Ying Zhai
Bernie R. Neustadt
Andrew W. Stamford
Eric M. Parker
Angelo Reggiani
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleNEUROPHARMACOLOGY
Characterization of the Potent and Highly Selective A2A Receptor Antagonists Preladenant and SCH 412348 [7-[2-[4-2,4-Difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in Rodent Models of Movement Disorders and Depression
Robert A. Hodgson, Rosalia Bertorelli, Geoffrey B. Varty, Jean E. Lachowicz, Angelo Forlani, Silva Fredduzzi, Mary E. Cohen-Williams, Guy A. Higgins, Francesco Impagnatiello, Elisa Nicolussi, Leonard E. Parra, Carolyn Foster, Ying Zhai, Bernie R. Neustadt, Andrew W. Stamford, Eric M. Parker, Angelo Reggiani and John C. Hunter
Journal of Pharmacology and Experimental Therapeutics July 1, 2009, 330 (1) 294-303; DOI: https://doi.org/10.1124/jpet.108.149617
Research ArticleNEUROPHARMACOLOGY
Characterization of the Potent and Highly Selective A2A Receptor Antagonists Preladenant and SCH 412348 [7-[2-[4-2,4-Difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in Rodent Models of Movement Disorders and Depression
Robert A. Hodgson, Rosalia Bertorelli, Geoffrey B. Varty, Jean E. Lachowicz, Angelo Forlani, Silva Fredduzzi, Mary E. Cohen-Williams, Guy A. Higgins, Francesco Impagnatiello, Elisa Nicolussi, Leonard E. Parra, Carolyn Foster, Ying Zhai, Bernie R. Neustadt, Andrew W. Stamford, Eric M. Parker, Angelo Reggiani and John C. Hunter
Journal of Pharmacology and Experimental Therapeutics July 1, 2009, 330 (1) 294-303; DOI: https://doi.org/10.1124/jpet.108.149617
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement